2026 NPPES data Internal Medicine Physician NPI 1992847644 MD
Verify on CMS →

ABISOLA AFOLALU, MD

Internal Medicine Physician in ORANGE, Connecticut. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
4K
Medicare Part D claims · 686 beneficiaries · Internal Medicine Physician avg: 3K
Generic prescribing
83%
generic claims · 17% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
93.5626/100
▲ 10 pts above national avg 83.1 · [object Object]
Industry payments
$19.51
1 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: ABISOLA AFOLALU, MD is a Internal Medicine Physician ([object Object]) practicing in ORANGE, Connecticut with a Medicare Part D prescribing footprint of 4K claims across 686 beneficiaries — 17% brand-name prescribing . Their CMS MIPS Final Score of 93.5626/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $19.51 across 1 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: ABISOLA AFOLALU, MD reported a CMS MIPS final score of 93.5626 out of 100, above the 83.1 national average, and filed 4,119 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

ABISOLA AFOLALU, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

ABISOLA AFOLALU, MD at a glance

High performer (top quartile)

NPI registry status

Active

Issued 02/12/2007

NPI 1992847644

Primary specialty

Internal Medicine Physician

High-volume

172,858 US NPIs in this specialty

Medicare Part D claims

4,119 52% vs specialty avg

2023 prescription claims

Specialty avg: 2,716

MIPS final score

93.5626/100 10.462600000000009% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Connecticut

How Internal Medicine Physician compares to other specialties among Connecticut providers

Connecticut providers

Internal Medicine Physician share within Connecticut

1. Internal Medicine Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Internal Medicine Physician share within Connecticut

Medicare quality performance — MIPS

ABISOLA AFOLALU, MD's 2023 MIPS final score plotted against the Internal Medicine Physician national average

High performer (top quartile)
MIPS Final Score
93.5626/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Internal Medicine Physician) — 93.5626/100 vs national avg 83.1

0%100%National avg83%93.6%
MIPS final score (Internal Medicine Physician) — 93.5626/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ABISOLA AFOLALU, MD is a Internal Medicine Physician provider practicing in ORANGE, Connecticut, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1992847644. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

ABISOLA AFOLALU, MD appears in the CMS NPPES registry as a Internal Medicine Physician provider holding MD credentials at 291 S LAMBERT RD STE 2, ORANGE, CT, 06477, with a listed phone of (475) 308-1909. NPI 1992847644 was issued on 02/12/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what AFOLALU most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 4,119 prescription claims written by this provider, covering 686 Medicare beneficiaries and totaling roughly $483K in drug spend, split 17% brand-name and 83% generic by claim count, with an opioid prescribing rate of 1.5%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 93.5626/100 for the 2023 performance year (Quality 78.5149), compared with the national average of 83.1.

Internal Medicine Physician is a high-volume specialty nationwide, with 172,858 enrolled providers across 56 states and an average of 2,716 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

291 S LAMBERT RD STE 2
ORANGE, CT 06477

Provider Details

NPI 1992847644
Specialty Internal Medicine Physician
Credentials MD
Gender Female
NPI Issued 02/12/2007

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

93.5626
Final Score
Avg: 83.1
78.5149
Quality
100
Promoting Interoperability

Reporting: Alternative Payment Model

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ABISOLA AFOLALU, MD. Source: openpaymentsdata.cms.gov.

Total received

$20

Largest payer

GlaxoSmithKline, LLC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

ABISOLA AFOLALU, MD — brand share 17.0%
Specialty average (est.)

17% brand-name claims vs 83% generic, on 4,119 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

4,119
Total Claims
$483K
Total Drug Cost
686
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
9,639
Total Day Supply
273,882
Brand vs Generic
17% brand / 83% generic
Brand Drug Cost
$396K
Generic Drug Cost
$84K
Opioid Claims
63 (1.5% rate)
Antibiotic Claims
64

Patient Demographics

Average Patient Age
73.5 years
Avg HCC Risk Score
1.17
Gender Split
64% female / 36% male
Age Distribution
<65: 50, 65-74: 340, 75-84: 229, 85+: 67

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Atorvastatin Calcium
269
Shingrix
Varicella-Zoster Ge/As01b/Pf
227
Amlodipine Besylate
200
Levothyroxine Sodium
186
Rosuvastatin Calcium
146
Lisinopril
131
Hydrochlorothiazide
119
Metformin Hcl
99
Losartan Potassium
77
Metoprolol Succinate
75

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Internal Medicine Physician Overview

How ABISOLA AFOLALU, MD fits within the Internal Medicine Physician landscape nationally.

172,858
Internal Medicine Physician Providers in US
56
States with Internal Medicine Physician
2,716
Avg Claims per Provider

ABISOLA AFOLALU, MD's 4,119 claims are above the specialty average of 2,716.

Nearby Internal Medicine Physician Providers in Connecticut

Other clinicians with the same primary specialty enrolled in Connecticut, drawn from the same CMS NPPES roster as AFOLALU.

Compare Internal Medicine Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ABISOLA AFOLALU, MD's specialty?
ABISOLA AFOLALU, MD specializes in Internal Medicine Physician and practices in ORANGE, Connecticut. Credentials: MD.
How much does ABISOLA AFOLALU, MD prescribe under Medicare Part D?
In 2023, ABISOLA AFOLALU, MD wrote 4,119 Medicare Part D claims totaling $483K in drug costs for 686 beneficiaries.
What is ABISOLA AFOLALU, MD's Medicare quality score?
ABISOLA AFOLALU, MD has a CMS MIPS Final Score of 93.5626/100 (Quality: 78.5149). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is ABISOLA AFOLALU, MD located?
ABISOLA AFOLALU, MD is located at 291 S LAMBERT RD STE 2, ORANGE, CT, 06477. Phone: (475) 308-1909.
What is ABISOLA AFOLALU, MD's NPI number?
ABISOLA AFOLALU, MD's National Provider Identifier (NPI) is 1992847644, issued on 02/12/2007.
Does ABISOLA AFOLALU, MD prescribe more brand-name or generic drugs?
ABISOLA AFOLALU, MD's prescribing is 17% brand-name and 83% generic drugs by claim count, with $396K in brand drug costs.
Does ABISOLA AFOLALU, MD prescribe opioids?
Yes, ABISOLA AFOLALU, MD had 63 opioid claims in 2023 with an opioid prescribing rate of 1.5%.
How many Internal Medicine Physician providers are there in the US?
There are 172,858 Internal Medicine Physician providers across 56 states in the US. The average Internal Medicine Physician provider writes 2,716 Medicare Part D claims per year.
What drugs does ABISOLA AFOLALU, MD prescribe most often?
Based on 2023 Medicare Part D data, ABISOLA AFOLALU, MD's most frequently prescribed drugs include Atorvastatin Calcium, Shingrix, Amlodipine Besylate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ABISOLA AFOLALU, MD accept Medicare?
ABISOLA AFOLALU, MD appears in CMS Medicare data with 4,119 Part D claims and 686 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ABISOLA AFOLALU, MD's credentials?
ABISOLA AFOLALU, MD's NPI is 1992847644 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology